Introduction
Haemoglobin Bart's hydrops fetalis syndrome (BHFS), also known as homozygous α 0 -thalassaemia major or homozygous α-thalassaemia 1, was first described in 1960. 1, 2 It was considered fatal in the 1960s to 1970s, 3 and fetuses often died in utero, were stillborn or died during the early neonatal period. 4 When prenatal screening and diagnosis for thalassaemia first started in Hong Kong in 1983, BHFS was advocated as an indication for termination of pregnancy. 5 Nonetheless, the availability of intrauterine transfusions (IUTs) 6, 7 and intrauterine exchange transfusions (IUETs) enabled affected fetuses to survive the perinatal period.
Since the world's first reported case of survival in 1985 in Canada, 8 increasing numbers of BHFS survivors have been reported worldwide, including in Hong Kong. 9 The traditional view of its fatality has been challenged, 10, 11 and in the 1990s there was lively debate about the ethical concerns surrounding active resuscitation and treatment of BHFS babies. Regular transfusions and iron chelation allow BHFS patients to survive even beyond adulthood, and haematopoietic stem cell transplantation [12] [13] [14] offers a cure for this disease, albeit at the expense of possible significant morbidities and compromised quality of life. Longterm morbidities for this cohort of patients thus become an important issue to address. Information gathered by this territory-wide retrospective study will assist physicians in contemplating perinatal management and counselling of parents.
Methods

Data collection
The setting for this study was all eight public hospital paediatric haematology units in Hong Kong that care for patients with transfusion-dependent thalassaemia. Records of patients diagnosed with BHFS (either antenatally or postnatally) who survived beyond the neonatal period and who were subsequently managed long-term at those units from 1 January 1996 to 31 December 2015 were retrieved from the Hong Kong Hospital Authority's Clinical Data Analysis and Reporting System using the International Classification of Diseases diagnostic code 282.7, searching only for Haemoglobin-Bart's disease. Data cross-checking was performed with the help of the Hong Kong Paediatric Haematology and Oncology Study Group and paediatric haematologists from the eight hospitals. Information about patient and parent characteristics, availability of antenatal care and diagnosis, antenatal ultrasonographic findings, reasons for continuation of pregnancy, use of intrauterine transfusions, perinatal course, presence of congenital malformations, subsequent neonatal and long-term neurodevelopmental outcome, and availability of stem-cell transplantation and subsequent outcomes were collected and studied. Patients with BHFS who were not born in Hong Kong were excluded from this study. No missing cases were identified during the 20-year study period, as confirmed from personal communications with both paediatric and adult haematologists from all public hospitals in Hong Kong. As BHFS pregnancies are considered high risk owing to possible maternal-fetal complications, it was presumed that no cases would have been managed by private doctors without support from a neonatal intensive care unit. 
Statistical analyses
Results
Demographic and genetic features
Surviving patients with BHFS were identified in five of the eight local paediatric haematology units. A total of nine infants were found, of whom five were female and four male. All patients were Chinese, and all were confirmed to be homozygous for the Southeast Asian α-thalassaemia deletion. Six pairs of parents were heterozygous for the Southeast Asian deletion, and three pairs refused genetic testing, one of which was suspected to be a case of non-paternity (case 7). For case 6, the mother was heterozygous for the Southeast Asian deletion (α-thalassaemia 1), whereas the father had an α3.7 single deletion (α-thalassaemia 2). The child demonstrated maternal uniparental disomy and isodisomy (Tables 1 and  2) . 6, [13] [14] [15] [16] [17] [18] [19] [20] Prenatal diagnosis, intrauterine management, and maternal complications Among the nine mothers, one received no antenatal care, two received antenatal care in a local private centre, and one received antenatal care in mainland China. All were considered normal and received no IUT. For the remaining five mothers who received antenatal care in a public hospital, all had BHFS diagnosed antenatally in their neonates (two by cordocentesis, one by chorionic villus sampling, one by amniocentesis, and one by both cordocentesis and chorionic villus sampling). All five couples decided to continue the pregnancy after counselling: two for religious reasons and three out of personal preference. All five patients had IUT/IUET performed two to four times. Antenatal ultrasonography of seven fetuses revealed cardiomegaly in four and hydropic changes in two, one of which subsequently resolved after IUT. Placentomegaly was detected in three mothers and polyhydramnios in one. Preeclampsia was reported in two mothers and was controlled with antihypertensive drugs (Tables 2 and  3) . 6, [13] [14] [15] [16] [17] [18] [19] [20] 
Neonatal outcomes and co-morbidities
Preterm delivery occurred in seven of the nine cases, with a median gestational age at delivery of 33 weeks. All infants had respiratory depression at birth and required resuscitation, neonatal intensive care unit admission, and intubation. Surfactant for respiratory distress syndrome was required by five infants, and five demonstrated persistent pulmonary hypertension of the newborn, which required high-frequency oscillation ventilation and inhaled nitric oxide administration. Inotropic support with or without hydrocortisone was required by four infants with haemodynamic instability (poor cardiac * Divorced mother with a 6-year-old child with α-thalassaemia trait and previous abortion at 20 weeks of gestation because of chickenpox infection; biological father was major carer since loss of contact with mother † Couple with known α-thalassaemia trait ‡ One stillbirth at 32 weeks of gestation in mainland China 13 years previously; one healthy baby boy delivered vaginally at term with birthweight 2.9 kg in Hong Kong 12 years previously; one surgical termination of pregnancy at first trimester in mainland China 7 years previously § Mother gave birth to a healthy baby 1 year later with different biological father; conceived again 2 years later (presumed same biological father as index case) but resulted in intrauterine death in first trimester because of haemoglobin Bart's hydrops fetalis contractility, heart failure, and/or hypotension). In case 6, the infant required cardiopulmonary resuscitation for more than 20 minutes after cardiac arrest. Postnatally, exchange transfusion was performed in five babies: two received a double-volume transfusion and three received a single-volume transfusion. Three infants received a transfusion within the first 24 hours of life. The median pre-and post-transfusion haemoglobin level was 90 and 170 g/L, respectively. All infants showed improved haemodynamic stability after transfusion. Congenital malformations were noted in all cases in this cohort (Tables 3 and 4) . 6, [13] [14] [15] [16] [17] [18] [19] All four male babies had hypospadias that required urethroplasty, and two had concomitant undescended testes that required orchidopexy. Dental (case 1) and skeletal (case 3) anomalies were noted in two patients. Regarding the cardiovascular system, patent ductus arteriosus was noted in five cases and a secundum atrial septal defect in three. Regarding the digestive system, one infant (case 3) had type 3 jejunal atresia, for which end-to-end anastomosis was performed on day 4 of life. Two patients had neonatal hepatitis: one case resolved with time and the other still requires regular followup for elevated transaminase levels. No cases of cerebrovascular malformations were identified in this local cohort.
Growth, puberty, and neurodevelopment
Both survivors who have reached adulthood are of short stature and have failed to achieve their final adult height, that is, to reach their predicted midparental height. Nonetheless, both had a normal puberty. Among the nine survivors, two have longterm neurological deficits, both manifested as mild spastic diplegia, although not affecting mobility. Five infants had delayed development, one of whom continues to have borderline low intellect (IQ, 80-89) after reaching adulthood (case 1). Two have normal intellect (cases 2 and 4) despite the need for multidisciplinary training during infancy, and the remaining two (cases 6 and 7) are attending mainsteam schools that provide extra training and support. The two cases diagnosed most recently (cases 8 and 9) have had normal development to date (Tables 3 and 4 ).
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Long-term outcomes and co-morbidities
Two patients received a stem-cell transplant: one an human leukocyte antigen DR 1 antigen-mismatch sibling-donor cord-blood transplant, and the other a 10/10 peripheral-blood stem-cell transplant from a matched unrelated donor. Both patients underwent transplantation at 20 to 21 months of age. Both achieved 100% donor chimerism 1 month after transplantation and remain transfusionindependent. Of the remaining seven patients who require regular transfusion every 3 to 6 weeks, only one shows moderate hepatic iron overload (case 2), and none have demonstrated infective complications. All five survivors older than 2 years received iron chelation therapy: three with deferasirox and two with deferiprone (one of whom has changed to deferoxamine owing to neutropenia). The median serum ferritin level was 1961 pmol/L (range, 411-5312 pmol/L). Endocrinopathies were noted in three patients: one had primary gonadal failure but did not require hormonal replacement therapy (case 1), one had hypogonadism requiring testosterone (case 5), and one (case 2) had partial adrenal insufficiency requiring stress-dose steroid but not regular hydrocortisone replacement (Tables  4 and 5 ).
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Discussion
In Southeast Asia, BHFS is the most common cause of fetal hydrops. 5, 21 Because it is an autosomal recessive disorder, when both parents have two α-globin gene deletions in cis on chromosome 16 (each parent, --/αα), any offspring will have a 25% chance of having BHFS. In BHFS, haemoglobin tetramers of only gamma chains (γ 4 ) is ineffective in erythropoiesis and oxygen delivery to tissues. The ensuing anaemia and tissue hypoxia interfere with organogenesis and development and also lead to fetal heart failure, extramedullary erythropoiesis, and maternal complications. In contrast to --FIL and --THAI gene deletions reported in the Philippines and Thailand, respectively, the --SEA or Southeast Asian deletion (the most common mutation in Hong Kong and demonstrated in all nine BHFS cases in this study) affects only the α-globin gene while sparing the embryonic ζ-globin gene, thus permitting production of Portland 1 (ζ 2 γ 2 ) and Portland 2 (ζ 2 β 2 ) haemoglobins. Hence, the affected fetus can survive through the antenatal and early neonatal period.
Pitfalls in prenatal screening and diagnosis
In Hong Kong, prenatal screening using a cut-off for maternal mean corpuscular volume of ≤80 fL and prenatal diagnosis using chorionic villus sampling, amniocentesis, and cordocentesis have been practised since 1983, [22] [23] [24] [25] thereby contributing to a decline in BHFS incidence for two decades. Despite public health endeavours in prenatal screening, however, BHFS babies continue to be born without prior prenatal diagnosis or parental counselling, resulting in adverse maternal and fetal outcomes. 26 Causes of this phenomenon are principally two-fold: lack of proper antenatal screening and diagnosis, as well as improper implementation of screening or diagnostic procedures (Table 1) . Better public education in both mainland China and Hong Kong would rectify LGA = large for gestational age; M = male; MAS = meconium aspiration syndrome; max = maximum; NEC = necrotising enterocolitis; NICU = neonatal intensive care unit; NO = nitric oxide; PDA = patent ductus arteriosus; PFO = patent foramen ovale; PPHN = pulmonary hypertension of newborn; PT = phototherapy; PVL = periventricular leukomalacia; RDS = respiratory distress syndrome; ROP = retinopathy of prematurity; SCBU = special care baby unit; SDH = subdural haemorrhage; SGA = small for gestational age; SIMV = synchronised intermittent mechanical ventilation; SpO 2 = oxygen saturation; SVD = spontaneous vaginal delivery; TPN = total parenteral nutrition; TPT = triple phototherapy; TR = tricuspid regurgitation; UDT = undescended testes * Urethroplasty and release of chordee done at 14 months of age. 27 Placental thickness measurement allows early detection of BHFS in the first trimester, even before the appearance of hydropic features. 18, 28 If 
Transplant-related complications Others
Anodontia by age 12 y, dental caries, deformation, malocclusion, occasional back pain, no history of fracture, bone mineral density Z-score -3.7
Transfusion pre-transplant (every 4 wk), transfusion-independent post-transplant without major complications on 15-y long-term follow-up, good exercise tolerance with running and basketball
Cord-blood transplant from matched-sibling donor, human leukocyte antigen DR antigen mismatch, aGVHD and human herpesvirus 6 viraemia in 1998 (see Table 5 for more details)
Hyperuricaemia, hypertriglyceridaemia, transient alopecia areata at age 6-7 y resolved, eczema, hyperextended elbow joints but normal range of movement None Transfusion (every 4 wk), on deferoxamine (deferiprone was stopped for neutropenia), MRI-T2* at age 18 y: moderate liver iron overload (T2* 1.4-2.7 ms), no cardiac iron overload (T2* >20 ms) Congenital malformations are often encountered, the most common being genitourinary and musculoskeletal defects, but are usually amenable to surgical correction. It is worth noting that all male babies in our local cohort displayed hypospadias. Two-thirds of our patient cohort showed growth retardation, global developmental delay, and/or long-term residual neurological deficits. These findings are comparable to those from an international case series 29 and an overseas case report. 11 Lifelong hypertransfusions every 4 to 6 weeks and iron chelation are expected for BHFS survivors. Haematopoietic stem-cell transplantation is a possible cure and has been successful in some local cases (Table 3) . Nevertheless, transplant-related mortality and morbidity should not be overlooked. The proposal that parents produce a subsequent sibling to serve as a 'saviour baby' and potential donor is feasible but raises ethical concerns. Careful consideration and proper parental counselling are necessary.
Comparison of outcomes and morbidities between local and international cohorts
Globally, 69 survivors are reported in the international BHFS registry 29 with our local cohort (n = 9) contributing about one-seventh of cases. Approximately two-thirds of all cases used IUT 29 (41/69; 59%), which is similar to the proportion of local cases (5/9; 56%). Globally 29 and locally, most infants were delivered prematurely (respectively, 47/66; 71% and 7/9; 78%). Approximately one-fifth (14/69) of all BHFS survivors underwent stem-cell transplantation, 29 again similar to our local situation (2/9). Congenital anomalies were present in all of the local patients, compared with two-thirds (37/55; 64%) worldwide, 29 although urogenital and limb defects remained the most common. Nearly half (26/55; 47%) of global BHFS survivors demonstrated various degrees of transient or permanent neurodevelopmental impairment, 29 in contrast to two-thirds of our cohort. Sohan et al (2002) 30 described the first BHFS survivor in the United Kingdom: a 38-week-old baby girl of Hong Kong parents, who was referred at 21 weeks of gestation for hydrops fetalis, received serial IUT and had BHFS antenatally diagnosed. Two exchange transfusions were performed postnatally and the baby was discharged on day 6 of life followed by transfusions every 4 to 5 weeks. At the time of that publication, she was 18 months old and had normal growth and development apart from bilateral transverse palmar creases and a mild lobster-claw deformity of the right foot. 30 
Strengths, limitations, and recommendations
This is the first territory-wide multicentre retrospective study to describe in depth the basic demographic characteristics and perinatal and longterm outcomes of BHFS survivors in Hong Kong over the past two decades or so. It also explores the reasons and cultural circumstances for which parents opted to continue the pregnancy despite public health endeavours to promote antenatal screening. Furthermore, it adds two more local cases to those submitted and recently published by the BHFS International Consortium. 29 However, the small sample size precludes statistical analyses, and the data covers only the eight local public hospitals with haematology units and a period of 20 years (as the cut-off age in Hong Kong for paediatric care is 20 years and the Clinical Data Analysis and Reporting System began only in 1996). Survivors beyond 20 years of age and patients who defaulted follow-up to receive long-term medical care in the private sector or overseas were excluded from this study. In addition, the numbers of abortions and stillbirths, as well as BHFS babies with early neonatal death were not studied. Multidisciplinary collaboration between obstetricians, paediatric haematologists, and adult-care physicians at all local hospitals and concerted efforts in data collection and analysis are recommended. With the establishment of the Hong Kong Children's Hospital in 2018, it is hoped that a standardised protocol of management and counselling can be compiled, data collection streamlined, and analysis facilitated for future research.
To conclude, survival of patients with BHFS is possible but not without short-and long-term complications. Local epidemiology of BHFS survivors is similar to that reported for an international registry. Detailed antenatal counselling of parents with a non-judgemental attitude and cautious optimism are imperative.
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